CH432504A - Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-nor-stéroïdes - Google Patents

Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-nor-stéroïdes

Info

Publication number
CH432504A
CH432504A CH752964A CH752964A CH432504A CH 432504 A CH432504 A CH 432504A CH 752964 A CH752964 A CH 752964A CH 752964 A CH752964 A CH 752964A CH 432504 A CH432504 A CH 432504A
Authority
CH
Switzerland
Prior art keywords
steroids
introducing
certain
oxygen function
oxygen
Prior art date
Application number
CH752964A
Other languages
English (en)
Inventor
Joly Robert
Warnant Julien
Jolly Jean
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of CH432504A publication Critical patent/CH432504A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH752964A 1963-07-10 1964-06-09 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-nor-stéroïdes CH432504A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR941004A FR1375078A (fr) 1963-07-10 1963-07-10 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-norstéroïdes et produits en résultant
FR951379A FR1468639A (fr) 1963-07-10 1963-10-22 Nouveau stéroïde diénique 11-oxygéné et procédé de préparation
FR960726A FR5089M (fr) 1963-07-10 1964-01-17
FR971005A FR3845M (fr) 1963-07-10 1964-04-15 Nouveau médicament notamment pour le traitement de l'hypercholestérolémie et des troubles en résultant.

Publications (1)

Publication Number Publication Date
CH432504A true CH432504A (fr) 1967-03-31

Family

ID=27445615

Family Applications (2)

Application Number Title Priority Date Filing Date
CH752964A CH432504A (fr) 1963-07-10 1964-06-09 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-nor-stéroïdes
CH753064A CH433276A (fr) 1963-07-10 1964-06-09 Procédé de préparation de nouveaux 19-nor-stéroïdes oxygénés en position 11

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH753064A CH433276A (fr) 1963-07-10 1964-06-09 Procédé de préparation de nouveaux 19-nor-stéroïdes oxygénés en position 11

Country Status (10)

Country Link
US (2) US3301756A (fr)
BE (2) BE649224A (fr)
BR (2) BR6459890D0 (fr)
CH (2) CH432504A (fr)
DE (2) DE1232577B (fr)
DK (2) DK112796B (fr)
FR (4) FR1375078A (fr)
GB (3) GB1074495A (fr)
NL (3) NL6406712A (fr)
SE (2) SE316170B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123455C (fr) * 1964-05-13
US3389153A (en) * 1965-08-13 1968-06-18 Merck & Co Inc 3-enol ethers of 17alpha-haloethynyl-estra 3, 5(10), 9(11)-trien-17beta-ols
FR205F (fr) * 1965-10-22
NL129874C (fr) * 1966-03-15
US3475469A (en) * 1967-06-27 1969-10-28 American Home Prod 13 - alkyl - 9 - chloromethylgon - 4-en-17beta-ol-3-ones and intermediates therefor
CN101208369B (zh) * 2005-06-28 2013-03-27 E.I.内穆尔杜邦公司 高功函数透明导体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same

Also Published As

Publication number Publication date
GB1074492A (en) 1967-07-05
NL6406711A (fr) 1965-01-11
BE649223A (fr)
GB1074491A (en) 1967-07-05
US3301756A (en) 1967-01-31
GB1074495A (en) 1967-07-05
NL6406712A (fr) 1965-01-11
FR5089M (fr) 1967-05-22
DE1232577B (de) 1967-01-19
SE316172B (fr) 1969-10-20
SE316170B (fr) 1969-10-20
FR1375078A (fr) 1964-10-16
DK112796B (da) 1969-01-20
NL121957C (fr)
FR3845M (fr) 1966-01-17
BR6459891D0 (pt) 1973-09-11
DE1229526B (de) 1966-12-01
CH433276A (fr) 1967-04-15
US3282785A (en) 1966-11-01
BE649224A (fr)
DK119107B (da) 1970-11-16
FR1468639A (fr) 1967-02-10
BR6459890D0 (pt) 1973-08-09

Similar Documents

Publication Publication Date Title
CH431753A (fr) Procédé et appareil d'usinage électrochimique
CH465627A (fr) Procédé de préparation d'un antibiotique
FR1407346A (fr) Procédé d'amélioration de la perméabilité
FR1473297A (fr) Nouvelles compositions anti-friction et procédé d'application
CH432504A (fr) Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-nor-stéroïdes
FR1415121A (fr) Purification de l'amide acrylique
FR1448762A (fr) Esters d'acides cyclododécadiène-carboxyliques
CH415961A (fr) Procédé de préparation d'un antibiotique
CH438246A (fr) Procédé de séparation de l'uranium et du plutonium
FR1512323A (fr) Nouveaux esters en 21 de dérivés cortisoniques
FR1363955A (fr) Alcène-2 oates d'homopérillyle
CH469745A (de) Procédé de préparation d'un copolymère
FR1399475A (fr) Instrument et procédé permettant d'engendrer des profils
FR1355028A (fr) Procédé d'illustration de cartes de présentation et cartes ainsi obtenues
FR3000M (fr) Nouveaux esters d'acides-alcools.
FR1386626A (fr) Compositions résineuses de nitrilopropionates et de polyvinyle
FR1375862A (fr) Procédé d'extraction liquide-liquide du béryllium
FR1383375A (fr) Alliages d'uranium perfectionnés
FR1393373A (fr) Appareil et procédé d'assemblage
FR1415322A (fr) Nouveaux composés de 3-sulfamidocyclobutanone et de 3-sulfamidocyclobutanol
FR3143M (fr) Amides d'acides β-phényl-β-oxypropionique et β-acéto-amido-β-phénylpropionique.
FR1388919A (fr) Procédé et installation métallurgiques
FR1492339A (fr) Procédé de coalescence d'émulsions
CH408601A (fr) Transporteur-vibrateur horizontal de distribution et d'orientation
CH392961A (fr) Briquet et procédé d'usinage de ce briquet